Last reviewed · How we verify

NCT06154915

Immune Cells in Diabetic Chronic Foot Ulcers

Recruiting now Last updated 3 September 2025
What this trial tests

trial testing medical treatments in Diabetic Foot in 40 participants. Currently enrolling.

Timeline
9 September 2022
Primary endpoint
31 December 2027
31 December 2029

Quick facts

Lead sponsorKarolinska Institutet
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date9 September 2022
Primary completion31 December 2027
Estimated completion31 December 2029
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 98, any sex, with Diabetic Foot or Immune Defect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn about the role of immune cells in patients with diabetes and chronic foot ulcers. Researchers will compare blood and tissue samples of patients with diabetes and a foot ulcer that is healing or healed compared to those diabetic patients where the foot ulcers is not healing (chronic ulcer).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Foot

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06154915.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing